Pharmacodynamic profile of prostacyclin
- 19 January 1995
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 75 (3) , 3A-10A
- https://doi.org/10.1016/s0002-9149(99)80377-4
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Interleukin 1 induces a shock-like state in rabbits. Synergism with tumor necrosis factor and the effect of cyclooxygenase inhibition.Journal of Clinical Investigation, 1988
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Increased Prostacyclin Biosynthesis in Patients with Severe Atherosclerosis and Platelet ActivationNew England Journal of Medicine, 1984
- Prostacyclin therapy in patients with congestive heart failureThe American Journal of Cardiology, 1982
- Treatment of Raynaud's phenomenon by intravenous infusion of prostacyclin (PGI2)British Journal of Dermatology, 1982
- Prostacyclin in experimental myocardial ischemia: Effects on hemodynamics, regional myocardial blood flow, infarct size and mortalityThe American Journal of Cardiology, 1981
- Topical prostacyclin (PGI2) inhibits platelet aggregation in pial venules of the mouse.Stroke, 1979
- Cyclic AMP inhibits synthesis of prostaglandin endoperoxide (PGG2) in human plateletsBiochemical and Biophysical Research Communications, 1976
- Prostaglandin feedback mechanism limits vasoconstrictor action of norepinephrine in perfused rabbit earCellular and Molecular Life Sciences, 1975
- Zur Kenntnis der pharmakologischen Wirkungen von Nativsekreten und Extrakten männlicher accessorischer GeschlechtsdrüsenNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1934